186 related articles for article (PubMed ID: 18206509)
1. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs.
Hankin CS; Cox L; Lang D; Levin A; Gross G; Eavy G; Meltzer E; Burgoyne D; Bronstone A; Wang Z
J Allergy Clin Immunol; 2008 Jan; 121(1):227-32. PubMed ID: 18206509
[TBL] [Abstract][Full Text] [Related]
2. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study.
Hankin CS; Cox L; Lang D; Bronstone A; Fass P; Leatherman B; Wang Z
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):79-85. PubMed ID: 20143650
[TBL] [Abstract][Full Text] [Related]
3. Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis.
Hankin CS; Cox L; Bronstone A; Wang Z
J Allergy Clin Immunol; 2013 Apr; 131(4):1084-91. PubMed ID: 23375206
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
Brüggenjürgen B; Reinhold T; Brehler R; Laake E; Wiese G; Machate U; Willich SN
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
[TBL] [Abstract][Full Text] [Related]
5. Utilization and cost of immunotherapy for allergic asthma and rhinitis.
Donahue JG; Greineder DK; Connor-Lacke L; Canning CF; Platt R
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):339-47. PubMed ID: 10227332
[TBL] [Abstract][Full Text] [Related]
6. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis.
Thomas M; Kocevar VS; Zhang Q; Yin DD; Price D
Pediatrics; 2005 Jan; 115(1):129-34. PubMed ID: 15629992
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma.
Nasser S; Vestenbaek U; Beriot-Mathiot A; Poulsen PB
Allergy; 2008 Dec; 63(12):1624-9. PubMed ID: 19032235
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
[TBL] [Abstract][Full Text] [Related]
10. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults.
Price D; Zhang Q; Kocevar VS; Yin DD; Thomas M
Clin Exp Allergy; 2005 Mar; 35(3):282-7. PubMed ID: 15784104
[TBL] [Abstract][Full Text] [Related]
11. Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns.
Crown WH; Olufade A; Smith MW; Nathan R
Value Health; 2003; 6(4):448-56. PubMed ID: 12859586
[TBL] [Abstract][Full Text] [Related]
12. Survey on the impact of comorbid allergic rhinitis in patients with asthma.
Valovirta E; Pawankar R
BMC Pulm Med; 2006 Nov; 6 Suppl 1(Suppl 1):S3. PubMed ID: 17140421
[TBL] [Abstract][Full Text] [Related]
13. Health care resource use and associated costs among patients with seasonal versus perennial allergic rhinitis.
Lang K; Allen-Ramey F; Huang H; Rock M; Kaufman E; Dykewicz MS
Allergy Asthma Proc; 2016 Sep; 37(5):103-11. PubMed ID: 27657517
[TBL] [Abstract][Full Text] [Related]
14. The health economics of allergen immunotherapy.
Hankin CS; Cox L; Bronstone A
Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of GRAZAX for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe.
Canonica GW; Poulsen PB; Vestenbaek U
Respir Med; 2007 Sep; 101(9):1885-94. PubMed ID: 17611095
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of acupuncture in women and men with allergic rhinitis: a randomized controlled study in usual care.
Witt CM; Reinhold T; Jena S; Brinkhaus B; Willich SN
Am J Epidemiol; 2009 Mar; 169(5):562-71. PubMed ID: 19126587
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of allergic rhinitis in Korea.
Kim SY; Yoon SJ; Jo MW; Kim EJ; Kim HJ; Oh IH
Am J Rhinol Allergy; 2010; 24(5):e110-3. PubMed ID: 21244726
[TBL] [Abstract][Full Text] [Related]
18. Rhinitis and its association with asthma in patients under 14 years of age treated in allergy departments in Spain.
Ibáñez MD; Navarro A; Sánchez MC; Rondón C; Montoro J; Matéu V; Lluch-Bernal M; Fernández-Parra B; Dordal MT; Dávila I; Conde J; Antón E; Colás C; Valero A;
J Investig Allergol Clin Immunol; 2010; 20(5):402-6. PubMed ID: 20945606
[TBL] [Abstract][Full Text] [Related]
19. [Allergic rhinitis in childhood--therapy and therapeutic success in a 5-year observation period].
Brunner FX
Laryngol Rhinol Otol (Stuttg); 1986 May; 65(5):260-3. PubMed ID: 3736289
[TBL] [Abstract][Full Text] [Related]
20. Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment.
Hay J; Jhaveri M; Tangirala M; Kaliner M
Allergy Asthma Proc; 2009; 30(6):634-42. PubMed ID: 20031009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
